Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study

Conclusions Rapid evidence products were considered invaluable to decision making. The credibility of EPs, a close relationship with SUs and having a highly skilled and adaptable team to meet the workload demands were identified as key strengths that optimised the utilisation of rapid evidence. Ethics approval Ethical approval was obtained from the National Research Ethics Committee for COVID-19-related Research, Ireland.
Source: Evidence-Based Medicine - Category: Internal Medicine Authors: Tags: Open access, General Medicine Original research Source Type: research